Estrogen Receptor-positive Invasive Metastatic Breast Cancer
📧 Sign up to get email alerts when something new happens for Estrogen Receptor-positive Invasive Metastatic Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Ruxolitinib in Estrogen Receptor Positive Breast Cancer [Phase 2]
Phase 2 clinical trial of ruxolitinib in estrogen receptor-positive invasive metastatic breast cancer completed with results posted.